MKS Inc. $MKSI Shares Sold by Lido Advisors LLC

Lido Advisors LLC decreased its stake in shares of MKS Inc. (NASDAQ:MKSI) by 34.6% during the 1st quarter, HoldingsChannel.com reports. The firm owned 3,929 shares of the scientific and technical instruments company’s stock after selling 2,078 shares during the quarter. Lido Advisors LLC’s holdings in MKS were worth $903,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in MKS by 3.6% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 267,421 shares of the scientific and technical instruments company’s stock worth $21,434,000 after buying an additional 9,170 shares during the last quarter. EverSource Wealth Advisors LLC increased its holdings in shares of MKS by 63.4% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 838 shares of the scientific and technical instruments company’s stock valued at $83,000 after acquiring an additional 325 shares during the last quarter. First Trust Advisors LP raised its position in shares of MKS by 3,545.6% during the 2nd quarter. First Trust Advisors LP now owns 141,267 shares of the scientific and technical instruments company’s stock valued at $14,036,000 after acquiring an additional 137,392 shares in the last quarter. Cerity Partners LLC acquired a new stake in shares of MKS during the 2nd quarter valued at approximately $1,676,000. Finally, AXA S.A. lifted its stake in MKS by 22.8% during the second quarter. AXA S.A. now owns 29,253 shares of the scientific and technical instruments company’s stock worth $2,907,000 after purchasing an additional 5,430 shares during the last quarter. 99.79% of the stock is owned by institutional investors.

Insider Transactions at MKS

In related news, Director Joseph B. Donahue sold 2,100 shares of MKS stock in a transaction dated Wednesday, May 27th. The shares were sold at an average price of $327.95, for a total value of $688,695.00. Following the sale, the director directly owned 10,033 shares in the company, valued at $3,290,322.35. This trade represents a 17.31% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CAO Michelle M. Mccarthy sold 2,434 shares of the business’s stock in a transaction dated Friday, June 5th. The shares were sold at an average price of $315.23, for a total transaction of $767,269.82. Following the transaction, the chief accounting officer directly owned 2 shares of the company’s stock, valued at $630.46. The trade was a 99.92% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 53,949 shares of company stock worth $17,446,108 over the last 90 days. Corporate insiders own 0.57% of the company’s stock.

Analyst Ratings Changes

MKSI has been the subject of several recent research reports. BMO Capital Markets began coverage on shares of MKS in a research note on Tuesday, June 30th. They set an “outperform” rating and a $453.00 target price for the company. Morgan Stanley raised their price target on shares of MKS from $374.00 to $442.00 and gave the stock an “overweight” rating in a research report on Monday, July 6th. TD Cowen reaffirmed a “buy” rating on shares of MKS in a report on Thursday, May 7th. Citigroup lifted their price target on shares of MKS from $355.00 to $425.00 and gave the company a “buy” rating in a report on Friday. Finally, Bank of America boosted their price objective on shares of MKS from $380.00 to $500.00 and gave the company a “buy” rating in a research report on Tuesday, June 23rd. One analyst has rated the stock with a Strong Buy rating, twelve have assigned a Buy rating, two have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $385.00.

MKS Trading Down 9.6%

NASDAQ:MKSI opened at $285.31 on Wednesday. The firm has a market capitalization of $19.27 billion, a P/E ratio of 59.69, a P/E/G ratio of 0.90 and a beta of 1.93. The business has a 50 day simple moving average of $351.54 and a 200 day simple moving average of $283.79. The company has a debt-to-equity ratio of 0.94, a current ratio of 1.11 and a quick ratio of 0.70. MKS Inc. has a 12-month low of $88.49 and a 12-month high of $447.62.

MKS (NASDAQ:MKSI) last issued its earnings results on Wednesday, May 6th. The scientific and technical instruments company reported $2.30 earnings per share for the quarter, topping the consensus estimate of $2.00 by $0.30. The firm had revenue of $1.08 billion for the quarter, compared to analyst estimates of $1.05 billion. MKS had a return on equity of 21.49% and a net margin of 8.06%.The firm’s revenue for the quarter was up 15.2% on a year-over-year basis. During the same period last year, the company earned $1.71 earnings per share. MKS has set its Q2 2026 guidance at 2.600-3.200 EPS. Equities research analysts predict that MKS Inc. will post 11.77 EPS for the current year.

MKS Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, June 12th. Investors of record on Wednesday, June 3rd were issued a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a dividend yield of 0.4%. The ex-dividend date of this dividend was Wednesday, June 3rd. MKS’s dividend payout ratio (DPR) is 20.92%.

About MKS

MKS Instruments, Inc (NASDAQ: MKSI) designs, manufactures and markets technology solutions that enable advanced processes in a variety of high‐technology and industrial markets. The company’s core offerings include vacuum and gas delivery systems, pressure and flow measurement instruments, optical metrology tools, photonics subsystems and critical components for manufacturing processes. These products support the precise control and monitoring needs of semiconductor, industrial manufacturing, life and health sciences, and research applications.

The company’s product portfolio features mass flow controllers, pressure transducers, vacuum gauges, gas purity monitors, laser-based metrology systems and photonic devices such as lasers and detectors.